CORNERSTONE THERAPEUTICS INC - FORM 10-K - EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - March 6, 2012

Attached files

file filename
10-K - FORM 10-K - CORNERSTONE THERAPEUTICS INCd275039d10k.htm
EX-10.50 - SEPARATION LETTER AGREEMENT AND GENERAL RELEASE - CORNERSTONE THERAPEUTICS INCd275039dex1050.htm
EXCEL - IDEA: XBRL DOCUMENT - CORNERSTONE THERAPEUTICS INCFinancial_Report.xls
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 - CORNERSTONE THERAPEUTICS INCd275039dex311.htm
EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 906 - CORNERSTONE THERAPEUTICS INCd275039dex321.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 - CORNERSTONE THERAPEUTICS INCd275039dex312.htm
EX-23.1 - CONSENT OF GRANT THORNTON LLP - CORNERSTONE THERAPEUTICS INCd275039dex231.htm
EX-32.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 906 - CORNERSTONE THERAPEUTICS INCd275039dex322.htm

Exhibit 21.1

SUBSIDIARIES OF THE REGISTRANT

 

     JURISDICTION OF
     INCORPORATION
NAME    OR ORGANIZATION

Aristos Pharmaceuticals, Inc.

    Delaware

Cornerstone BioPharma, Inc.

    Nevada

Cornerstone BioPharma Holdings, Inc.

    Delaware

Cardiokine, Inc.

    Delaware

Cardiokine Biopharma, LLC

    Delaware

Cardiokine Ireland, Limited

    Ireland

Stock widget

Investing forum

CORNERSTONE THERAPEUTICS INC Reports